June 13, 2018
Corium Annouces Issuance of Key U.S. Patent Covering CorplexTM Donepezil Transdermal System for Alzheimer’s Disease
Provides Composition of Matter Coverage to 2037 MENLO PARK, Calif. , June 13, 2018 (GLOBE NEWSWIRE) — Corium International, Inc. (NASDAQ:CORI), a commercial stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, announced…